Motility disorders Flashcards

1
Q

What are motility disorders of oesophagus

A
  • Abnormal peristalsis
  • Present with difficulty swallowing usually solids and liquids
  • Less common than inflammatory or malignancy of oesophagus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anatomy of oesophagus - part and type of muscle

A
  • Upper 1/3 - skeletal muscle
  • Middle 1/3 - transition zone of both skeletal and smooth muscle
  • Lower 1/3 - smooth muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is LOS vs UOS composed of?

A
  • UOS - skeletal
  • LOS - smooth muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What initiates oesophageal motion?

A
  • Oesophageal myenteric neurones control peristaltic waves
  • Primary wave under control of swallowing centre, secondary wave in response to distension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens as food moves down oesophagus?

A

LOS relaxes and allows food to pass into stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is achalasia?

A
  • Primary motility disorder
  • Failure of relaxation of LOS and absence of peristalsis along oesophageal body
  • Underlying cause though to be progressive destruction of ganglion cells in myenteric plexus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk with achalasia

A
  • Increased risk of oesophageal cancer by 8-16x
  • Absolute risk remains low though
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Symptoms of achalasia

A
  • Progressive dysphagia solids and liquids
  • Regurgitation of food
  • Symptom severity varies day to day
  • Others can be respiratory complications eg nocturnal cough, aspiration, chest pain, dyspepsia, weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Examination findings for achalasia

A
  • Rarely any signs
  • Visible weight loss - secondary to reduced oral intake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Investigations for motility disorder presentation

A
  • Anyone with dysphagia - upper GI endoscopy - if severe can be dilated oesophagus with retained food and increased resistance GOJ
  • Oesophageal manometry = gold standard
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is oesophageal manometry

A
  • Pressure sensitive probe into oesophagus (5cm proximal to LOS)
  • Measures pressure of sphincter and surrounding muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3 key features on manometry of achalasia

A
  • Absence of oesophageal peristalsis
  • Failure of relaxation of LOS
  • High resting LOS tone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Classification of achalasia

A
  • Chicago classification
  • Based on contractility pattern in oesophageal body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chicago classification

A
  • Type I - classical achalasia, 100% failed peristalsis, LOS fails to relax completely
  • II - pan-oesophageal pressuriation to >30mmHg in 20% of swallows at least, no normal peristalsis
  • III - no normal peristalsis, preserved fragments of distal peristalsis OR premature contractions in more than 20% of swallows
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Conservative management achalasia

A
  • Sleeping with multiple pillows - reduce regurgitation
  • Eating slowly
  • Chewing food thoroughly
  • Plenty of fluid with meals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pharmacological options for achalasia

A
  • CCBs - typically subligual Nifedipine to inhibit LOS contraction BUT benefit short lived
  • Botox injections into LOS via endoscopy can be trialled, effects only last few months though
17
Q

Surgical options for achalasia

A
  • Laparascopic Heller Myotomy (cardiomyotomy)
  • Per oral endoscopic myotomy (POEM)
  • Endoscopic balloon dilatation
18
Q

Laparascopic heller myotomy (cardiomyotomy)

A
  • Division of specific fibres of LOS which fail to relax
  • Only divide muscle fibres and avoid mucosal breach
19
Q

Per oral endoscopic myotomy

A
  • Cardiomyotomy at LOS performed from inside lumen of oesophagus - through a submucosal tunnel
  • Post op rates of GORD are high though but good clinical response
19
Q

Laparascopic heller myotomy vs other approaches

A
  • Long term swallowing improvement in 85%
  • Lower side effects than endoscopic
  • Reflux becomes a problem after so partial fundoplication usually done at same time
20
Q

Endoscopic balloon dilatation

A
  • Insertion of balloon into LOS which is dilated to stretch muscle fibres
  • Good response initially but risk of perforation and need for further intervention later
21
Q

Management of end stage refractory achalasia

A
  • May need oesophagectomy eventually
  • If unsuitable, cardioplasty (cutting out LOS and anastomosing) may be done
22
Q

What is diffuse oesophageal spasm?

A
  • Multi-focal high amplitude contractions of oesophagus
  • Dysfunction of oesophagus inhibitory nerves
  • Sometimes can progress to achalasia
23
Q

Symptoms of diffuse oesophageal spasm

A
  • Severe dysphagia - solids and liquids
  • Central chest pain - exacerbated by food
  • Pain can respond to nitrates - due to relaxation of muscle, making if difficult to distinguish from angina
24
Q

Examination diffuse oesophageal spasm

A

normal - like achalasia

25
Q

Investigations for DOS

A
  • Need upper GI endoscopy first - like any dysphagia
  • Then definitve diagnosis via manometry
  • Barium swallow less commonly used but can reveal corkscrew appearance
26
Q

Manometry findings for diffuse oesophageal spasm

A
  • Repetitive, simultaneous contractions of oesophagus
  • Concurrent dysfunction of LOS
27
Q

Management diffuse oesophageal spasm

A
  • CCB - relax smooth muscle in oesophagus
  • Pneumatic dilation or Heller myotomy if refractory
28
Q

Other causes of dysmotility

A
  • Autoimmune and CTD disorders
  • eg systemic sclerosis (most common), polymyositis and dermatomyositis
  • Managed via treating underlying disease, nutritional modification and PPIs as needed
29
Q
A